Mesoblast (MESO) Change in Cash (2016 - 2023)
Mesoblast (MESO) posted Change in Cash of $22.5 million for Q2 2023, up 219.88% sequentially from -$18.8 million in Q1 2023, and up 239.23% YoY from $6.6 million in Q2 2022.
Mesoblast (MESO) Change in Cash (2016 - 2023) Analysis & Trends
Mesoblast has reported Change in Cash for 8 years, with the latest figure at $22.5 million in Q2 2023.
- Quarterly Change in Cash rose 239.23% year-over-year to $22.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $11.0 million (up 114.55% YoY) and the FY2025 annual result came in at $97.5 million, up 1274.3% from the prior year.
- Change in Cash grew to $22.5 million in Q2 2023 per MESO's latest filing, from -$18.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $81.0 million in Q1 2021 and troughed at -$31.7 million in Q4 2020.
- A 5-year average of -$439500.0 and a median of -$18.3 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2020 and 2021: Change in Cash plunged 208.58% in 2020, then soared 491.98% in 2021.
- Over 5 years, Change in Cash stood at $46.4 million in 2019, then sank by 168.33% to -$31.7 million in 2020, then jumped by 33.25% to -$21.2 million in 2021, then rose by 12.66% to -$18.5 million in 2022, then soared by 221.59% to $22.5 million in 2023.
- According to Business Quant data, Change in Cash over the past three periods registered $22.5 million, -$18.8 million, and -$18.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 22.50 Mn |
| Mar 31, 2023 | -18.76 Mn |
| Dec 31, 2022 | -18.50 Mn |
| Sep 30, 2022 | 25.81 Mn |
| Jun 30, 2022 | -16.16 Mn |
| Mar 31, 2022 | -18.10 Mn |
| Dec 31, 2021 | -21.18 Mn |
| Sep 30, 2021 | -20.45 Mn |
| Jun 30, 2021 | -21.38 Mn |
| Mar 31, 2021 | 80.96 Mn |
| Dec 31, 2020 | -31.73 Mn |
| Sep 30, 2020 | -21.71 Mn |
| Jun 30, 2020 | 67.47 Mn |
| Mar 31, 2020 | -20.65 Mn |
| Dec 31, 2019 | 46.44 Mn |
| Sep 30, 2019 | -15.85 Mn |
| Jun 30, 2019 | -19.92 Mn |
| Mar 31, 2019 | -6.69 Mn |
| Dec 31, 2018 | 21.91 Mn |
| Sep 30, 2018 | 17.52 Mn |